Association between preeclampsia and the CXC chemokine family (Review)

Xijing Liu1, L I Dai1, Rong Zhou1

  • 1Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Insights

Preeclampsia, a condition causing hypertension and proteinuria in pregnancy, may involve CXC chemokines. These proteins regulate blood vessel formation and inflammation, potentially playing a role in preeclampsia development.

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Vascular Biology

Background:

  • Preeclampsia is a leading cause of maternal and perinatal mortality.
  • It is characterized by gestational hypertension, proteinuria, and systemic inflammation.
  • The exact cause remains unknown, but inadequate trophoblast invasion and endothelial dysfunction are implicated.

Purpose of the Study:

  • To explore the potential role of chemokines, specifically CXC chemokines, in the pathogenesis of preeclampsia.
  • To understand how CXC chemokines, which regulate angiogenesis, might contribute to preeclampsia's development.

Main Methods:

  • Review of existing literature on preeclampsia, chemokines, and angiogenesis.
  • Analysis of the known functions of CXC chemokine subfamilies (ELR+ and ELR-).

Main Results:

  • CXC chemokines are involved in angiogenesis, immunity, and cell trafficking.
  • The CXC chemokine family is divided into pro-angiogenic (CXC ELR+) and anti-angiogenic (CXC ELR-) subfamilies.
  • CXC chemokines are implicated in various diseases, including inflammation and atherosclerosis, suggesting a potential role in preeclampsia.

Conclusions:

  • CXC chemokines are key regulators of angiogenesis and inflammation.
  • Their dysregulation may contribute to the endothelial dysfunction observed in preeclampsia.
  • Further research is warranted to elucidate the specific role of CXC chemokines in preeclampsia pathogenesis.